EORTC-04891-ECSG

Essais cliniques phase II d'une nouvelle nitrosourée: la Cystémustine dans les poumons, les adénocarcinomes colo-rectaux, les gliomes, les mélanomes, les reins, les sarcomes des parties molles et les tumeurs de la tête et du cou.
Trial StatusAll trial activities ended
DatesDate of activation: 15-Jan-90
Closed on : 02-Jan-96
Data management at EORTCFull
Phase2
Randomized trialNo
TypeAdvanced
Targeted Sample size150
Number of steps1
Drug
Study Staff
Type of cancerLung
Melanoma
Brain
Kidney
Colon
Soft Tissue and Bone Sarcoma
Head and Neck
Participating GroupsEORTC Early Clinical Studies Group(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT number
EudraCT